
Health industries quarterly insights: Q1 2025
The health industries quarterly offers insights on accounting and reporting hot topics impacting the industry.
Pharmaceutical and life sciences companies are facing increasingly complex challenges globally and must have the scientific, commercial and operational capabilities to compete and deliver value for patients and investors. PwC’s sector team combines our industry knowledge, experience and technology to help create sustained outcomes for your business. We work with leaders across the value chain to help you innovate, thrive and grow, every step of the way.
Our team of industry specialists is committed to helping your organization deliver positive outcomes for patients and investors. We can help you reinvent your business model by reshaping portfolios, innovating the patient experience, digitizing the value chain, resetting the cost base and transacting to transform.
The health industries quarterly offers insights on accounting and reporting hot topics impacting the industry.
2025 marks the beginning of a year for action on a significant “must-pass” tax bill.
Four strategic bets and a suite of capabilities for the pharma industry to help you determine how your company can create value in the future.
Emerging biotech companies are poised to revolutionize healthcare, with board members playing a critical role in navigating this complex, regulated industry.
Health Industries Leader, PwC US
Health Industries Assurance Leader, Global Engagement Partner, PwC US
As the Health Industries Trust Solutions Leader, I’m guided by my passion for excellent service in helping our clients navigate complex problems across the sector.
Pharmaceutical & Life Sciences Advisory Leader, PwC US
Pharmaceutical & Life Sciences Tax Leader, PwC US